- Report
- March 2024
- 193 Pages
Global
From €3217EUR$3,374USD£2,757GBP
€3575EUR$3,749USD£3,064GBP
- Report
- March 2024
- 199 Pages
Global
From €3217EUR$3,374USD£2,757GBP
€3575EUR$3,749USD£3,064GBP
- Report
- January 2024
- 125 Pages
Global
From €5673EUR$5,950USD£4,863GBP
- Report
- October 2023
- 150 Pages
Global
From €5673EUR$5,950USD£4,863GBP
- Report
- May 2024
- 136 Pages
Global
From €6197EUR$6,499USD£5,311GBP
- Report
- May 2024
- 179 Pages
Global
From €4720EUR$4,950USD£4,045GBP
- Report
- February 2024
- 181 Pages
Global
From €4672EUR$4,900USD£4,004GBP
- Report
- November 2023
- 180 Pages
Global
From €4672EUR$4,900USD£4,004GBP
- Report
- March 2024
- 200 Pages
Global
From €3957EUR$4,150USD£3,392GBP
- Report
- January 2024
- 143 Pages
Global
From €4052EUR$4,250USD£3,473GBP
- Report
- April 2024
- 172 Pages
Global
From €2384EUR$2,500USD£2,043GBP
- Report
- December 2023
- 180 Pages
Global
From €4572EUR$4,795USD£3,919GBP
- Report
- December 2023
- 80 Pages
United States
From €2474EUR$2,595USD£2,121GBP
- Report
- May 2024
- 138 Pages
Global
From €6197EUR$6,499USD£5,311GBP
- Report
- May 2024
- 140 Pages
Global
From €6197EUR$6,499USD£5,311GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2860EUR$3,000USD£2,452GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1907EUR$2,000USD£1,634GBP
- Drug Pipelines
- April 2024
- 250 Pages
Global
From €2860EUR$3,000USD£2,452GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1192EUR$1,250USD£1,022GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1192EUR$1,250USD£1,022GBP
The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition.
Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more